Transactions
Deal Showcase
$125 Million
Joint Bookrunner
Follow-On
February 2023
More Transactions
$119 Million
Joint Bookrunner
Follow-On
October 2021
$150 Million
Joint Bookrunner
Follow-On
December 2023
$35 Million
Exclusive Financial Advisor
Series C Financing Led by MultiPlan Corporation
June 2022
Featured Insights
Podcasts
August 2025
Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA
Featured Research
August 2025
ABVX / Ph3 ABTECT Induction Data Preview; A Key Value-Inflecting Catalyst for ABVX / Outperform
Articles
June 2025
Drug Launch Superstars: Where are They Now?
